Zaeske Adam H. has filed 4 insider transactions across 1 company since April 2025.
Most recent transaction: a grant/award of 56900 shares of Harmony Biosciences Holdings, Inc. ($HRMY) on January 22, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 22, 2026 | Harmony Biosciences Holdings, Inc. | $HRMY | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | A | Stock Option | 56900 | $0.00 | 56,900.0000 | 58,544,570 | 9999.99% | 0.10% |
| Jan. 22, 2026 | Harmony Biosciences Holdings, Inc. | $HRMY | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | A | Restricted Stock Units | 16200 | $0.00 | 16,200.0000 | 58,544,570 | 9999.99% | 0.03% |
| April 7, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | A | Stock Option | 100000 | $0.00 | 100,000.0000 | 58,524,566 | 9999.99% | 0.17% |
| April 7, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | A | Restricted Stock Units | 30000 | $0.00 | 30,000.0000 | 58,524,566 | 9999.99% | 0.05% |